This site uses cookies.
Some of these cookies are essential to the operation of the site,
while others help to improve your experience by providing insights into how the site is being used.
For more information, please see the ProZ.com privacy policy.
This person has a SecurePRO™ card. Because this person is not a ProZ.com Plus subscriber, to view his or her SecurePRO™ card you must be a ProZ.com Business member or Plus subscriber.
Affiliations
This person is not affiliated with any business or Blue Board record at ProZ.com.
Source text - English WHY IS THIS STUDY BEING DONE?
The comany has begun a research study of the drug ??, as a possible treatment for multiple myeloma that has failed to respond to other treatment (relapsed refractory multiple myeloma). ?? is a drug that is often used to treat other diseases (for example leprosy, recurrent ulcers, and skin disease), but recent studies have shown that it may also be an effective treatment for relapsed refractory multiple myeloma.
The purpose of this study is to look at how effective and safe ?? is (at 3 different doses, because we are not sure which dose is best) when used to treat patients with relapsed refractory multiple myeloma, compared to a drug called ??. ?? is a type of steroid which has proven to be effective in advanced myeloma.
You are being invited to take part in this research study because you have been diagnosed with relapsed refractory multiple myeloma - that is, myeloma that is getting worse or is not controlled with other treatments.
Translation - Malayalam I paThanam enthinu naTaththunnu?
Medical
Case Report Forms (CRF)
Instructions for Use (IFU)
Clinical Protocols
Clinical Trials
Informed Consent Forms
Patient Information
Patient Questionnaires
Pharmacological Studies
Production Manuals
Computer (General)
Law
Advertising and Public Relations
Health
Banking
Trusted by Several Clients and
Most Competitive Rate
